Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 22 studies | 52% ± 27% | |
connective tissue cell | 8 studies | 53% ± 25% | |
astrocyte | 7 studies | 28% ± 9% | |
kidney loop of Henle epithelial cell | 6 studies | 42% ± 14% | |
basal cell | 6 studies | 35% ± 23% | |
epithelial cell of proximal tubule | 5 studies | 74% ± 10% | |
epithelial cell | 5 studies | 49% ± 27% | |
myofibroblast cell | 5 studies | 56% ± 22% | |
GABAergic neuron | 5 studies | 29% ± 9% | |
adventitial cell | 4 studies | 24% ± 5% | |
keratinocyte | 4 studies | 67% ± 15% | |
retinal bipolar neuron | 3 studies | 42% ± 13% | |
abnormal cell | 3 studies | 49% ± 16% | |
rod bipolar cell | 3 studies | 68% ± 16% | |
pericyte | 3 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 18430.40 | 89 / 89 | 83% | 697.38 | 751 / 901 |
breast | 94% | 18611.82 | 433 / 459 | 65% | 648.20 | 726 / 1118 |
intestine | 51% | 5939.56 | 493 / 966 | 71% | 230.51 | 374 / 527 |
thymus | 60% | 4221.33 | 393 / 653 | 53% | 552.09 | 322 / 605 |
esophagus | 35% | 2553.25 | 499 / 1445 | 73% | 455.48 | 133 / 183 |
skin | 72% | 38941.62 | 1305 / 1809 | 20% | 81.58 | 96 / 472 |
adipose | 92% | 21360.74 | 1109 / 1204 | 0% | 0 | 0 / 0 |
bladder | 48% | 2774.00 | 10 / 21 | 41% | 189.36 | 207 / 504 |
brain | 54% | 3533.59 | 1427 / 2642 | 28% | 80.07 | 200 / 705 |
stomach | 16% | 836.14 | 59 / 359 | 64% | 213.14 | 182 / 286 |
pancreas | 2% | 85.96 | 8 / 328 | 74% | 294.17 | 131 / 178 |
spleen | 61% | 5202.80 | 147 / 241 | 0% | 0 | 0 / 0 |
uterus | 9% | 809.87 | 15 / 170 | 44% | 223.45 | 202 / 459 |
muscle | 53% | 3025.07 | 424 / 803 | 0% | 0 | 0 / 0 |
lung | 3% | 152.88 | 20 / 578 | 49% | 265.72 | 568 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 51% | 297.51 | 23 / 45 |
blood vessel | 50% | 4362.91 | 665 / 1335 | 0% | 0 | 0 / 0 |
prostate | 4% | 341.97 | 10 / 245 | 30% | 61.27 | 152 / 502 |
liver | 18% | 746.95 | 41 / 226 | 2% | 5.84 | 9 / 406 |
ovary | 3% | 129.58 | 5 / 180 | 17% | 31.73 | 73 / 430 |
lymph node | 0% | 0 | 0 / 0 | 14% | 25.59 | 4 / 29 |
heart | 4% | 230.27 | 37 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 3.06 | 3 / 80 |
adrenal gland | 1% | 25.09 | 2 / 258 | 3% | 63.17 | 6 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0006935 | Biological process | chemotaxis |
GO_0060326 | Biological process | cell chemotaxis |
GO_0007267 | Biological process | cell-cell signaling |
GO_0005615 | Cellular component | extracellular space |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005515 | Molecular function | protein binding |
GO_0008009 | Molecular function | chemokine activity |
Gene name | CXCL14 |
Protein name | C-X-C motif chemokine 14 (Chemokine BRAK) (MIP-2G) (Small-inducible cytokine B14) C-X-C motif chemokine ligand 14 |
Synonyms | UNQ240/PRO273 PSEC0212 NJAC MIP2G SCYB14 |
Description | FUNCTION: Potent chemoattractant for neutrophils, and weaker for dendritic cells. Not chemotactic for T-cells, B-cells, monocytes, natural killer cells or granulocytes. Does not inhibit proliferation of myeloid progenitors in colony formation assays. . |
Accessions | ENST00000512158.6 A0A0C4DGC1 O95715 ENST00000337225.5 |